[Percutaneous ethanol injection in combination with euthyrox suppressive therapy in the treatment of benign nodular goiter].

This study was designed to clarify the efficacy of combination of thyroid hormone (euthyrox) therapy and percutaneous ethanol injection (PEI) in benign nodular thyroid diseases. 55 patients with benign nodular goiter after the first PEI session during the whole study period (from 3 till 12 months after PEI) daily received euthyrox in a dosage - 50 mkg. 48 women and 7 men with thyroid nodules of the various sizes, structures and echogenecity have been included in the study group.

Effectiveness of percutaneous ethanol injection therapy in benign nodular and cystic thyroid diseases: 12-month follow-up experience.

This study was designed to clarify the long-term efficacy of percutaneous ethanol injection (PEI) therapy in benign nodular and cystic thyroid diseases. Solid nodule and complex cyst were classified into three groups in accordance with volume reduction. In solid nodule (n = 38) and complex cyst (n=8), initial volume was significantly reduced to final volumes, and volume reduction persisted during follow-up period.

[Study of dopamine effect on neuroendocrine disorders during polycystic-ovary syndrome using the method of enzyme-linked immunosorbent analysis (ELISA)].

The goal of this work was to study the influence of chronic stress on the development of neuroendocrine disorders and to establish the role of hypothalamo-dopaminergic system in the formation of polycystic-ovary syndrome (POS) of central form. Our data indicate that an increase of luteinizing hormone (LH) in the blood of patients diagnosed with POS of central genesis is conditioned both by the decrease of the influence of dopaminergic system and increased secretory activity of LH releasing generating neutrons causing chronic stress. Thus the fact that well-pronounced decrease of dopamine level is observed in persons forcedly displaced evidences that chronic stress is an important risk factor of the development of POS of central genesis.